HTS Pharma
San Diego, California, United States
Disclosure information not submitted.
369 - Fosmanogepix Expanded Access Experience in Patients With Invasive Aspergillosis
Tuesday, October 21, 2025
12:30 PM - 12:35 PM US ET
370 - Fosmanogepix Expanded Access Experience in Patients With Fusarium Infections
Tuesday, October 21, 2025
12:35 PM - 12:40 PM US ET